Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK ® (deutivacaftor/tezacaftor/vanzacaftor) for the treatment of people with cystic ...

Vertex Pharmaceuticals (VRTX) on Tuesday announced that the European Commission has granted approval for Alyftrek for the ...

There are at least six kinds of diabetes you should know about. Endocrinologists explain the causes, symptoms, and treatments ...

An inhaled gene therapy for cystic fibrosis developed by Boehringer Ingelheim is due to start clinical testing shortly, hoping to become a first-in-class treatment for the genetic disorder ...

Funding cuts and sky-high inflation have made researchers in Argentina thrifty and creative. What can U.S. colleagues learn ...

Uncovering India's genetic richness through comprehensive genomic mapping reveals unique ancestry and health implications for ...

This article appeared in the Spring/Summer 2025 issue of Hopkins Bloomberg Public Health magazine.Three more months.That's ...

Factors such as inactivity, excess weight, and certain ethnic backgrounds increase the risk of developing type 2 diabetes.

But I've come to find out Gwada negative now makes it 48 different blood types. We don’t hear about them because they’re so ...

Learn how precision medicine leverages genetics, AI, and big data to deliver personalized healthcare, transforming treatments and outcomes.